Schlosser Mario 4
4 · Oscar Health, Inc. · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Oscar Health (OSCR) Director Mario Schlosser Sells Shares
What Happened
- Director Mario Schlosser converted 47,500 Class B/derivative shares into Class A common stock and, on the same date (July 1, 2026), sold 47,500 shares in three open-market transactions. Total cash proceeds from the sales were approximately $1,484,014.
- Sales breakdown: 3,600 shares at $29.50 ($106,200); 13,672 shares at $30.80 ($421,098); 30,228 shares at $31.65 ($956,716). The conversion entries show no cash was exchanged for the derivative-to-equity conversion.
Key Details
- Transaction date: July 1, 2026 (report filed July 6, 2026; Period of Report 2026-07-01).
- Proceeds: ~$1,484,014 total; weighted average price across the 47,500 sold shares ≈ $31.24.
- Plan/authorization: Sales were effected under a Rule 10b5-1 trading plan adopted March 24, 2026 (Footnote F1).
- Conversion note: Class B common is convertible one-for-one into Class A common (Footnote F2); conversion appears to be a non-cash exchange in this filing.
- Pricing detail: The filing discloses weighted-average prices and price ranges for the grouped sales (Footnotes F4–F6) and offers to provide per-price quantities on request.
- Ownership notes: The filer disclaims beneficial ownership of shares held of record by a trust except to the extent of any pecuniary interest (Footnote F3). The filing also notes inclusion of shares to be issued in connection with RSU vesting (Footnote F7).
- Timeliness: Filing shows a July 6, 2026 submission for July 1 transactions; no late-filing flag was indicated in the summary provided.
Context
- This was a sale of converted shares (conversion + immediate open-market disposition on the same date), not a purchase. Sales under a pre-established 10b5-1 plan are typically scheduled trades and are often treated as routine rather than a real-time signal of the insider’s view.
- For retail investors, purchases typically carry more weight as a bullish signal; here the filing documents conversion and monetization of shares rather than an accumulation of new stock.
Insider Transaction Report
Form 4
Schlosser Mario
Director
Transactions
- Conversion
Class A Common Stock
[F1][F2][F3]2026-07-01+47,500→ 47,500 total(indirect: By Trust) - Sale
Class A Common Stock
[F1][F4][F3]2026-07-01$29.50/sh−3,600$106,200→ 43,900 total(indirect: By Trust) - Sale
Class A Common Stock
[F1][F5][F3]2026-07-01$30.80/sh−13,672$421,098→ 30,228 total(indirect: By Trust) - Sale
Class A Common Stock
[F1][F6][F3]2026-07-01$31.65/sh−30,228$956,716→ 0 total(indirect: By Trust) - Conversion
Class B Common Stock
[F2][F1][F3]2026-07-01−47,500→ 538,333 total(indirect: By Trust)→ Class A Common Stock (47,500 underlying)
Holdings
- 480,866
Class A Common Stock
[F7] - 283,333(indirect: By Trust)
Class B Common Stock
[F2][F3]→ Class A Common Stock (283,333 underlying) - 283,333(indirect: By Trust)
Class B Common Stock
[F2][F3]→ Class A Common Stock (283,333 underlying) - 1,212,293
Class B Common Stock
[F2]→ Class A Common Stock (1,212,293 underlying)
Footnotes (7)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2026.
- [F2]The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
- [F3]Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.05 to $30.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $31.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F7]Includes shares to be issued in connection with the vesting of one or more restricted stock units.
Signature
/s/Melissa Curtin, Attorney-in-Fact|2026-07-06